메뉴 건너뛰기




Volumn 55, Issue 1, 2008, Pages 65-70

Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients

Author keywords

Capecitabine; Colorectal cancer; Liver metastases; Oxaliplatin; XELOX

Indexed keywords

BEVACIZUMAB; CAPECITABINE; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; XELOX;

EID: 48149087472     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (14)

References (37)
  • 1
    • 33846939792 scopus 로고    scopus 로고
    • Cooper Survival after hepatic resection in metastatic colorectal cancer: A population-based study
    • Published Online: 19 Jan 2007
    • LINDA C. CUMMINGS, JONATHAN D. PAYES, GREGORY S. Cooper Survival after hepatic resection in metastatic colorectal cancer: A population-based study, Cancer, 718-726 Published Online: 19 Jan 2007,
    • Cancer , pp. 718-726
    • Cummings, L.C.1    Payes, J.D.2    Gregory, S.3
  • 2
    • 0029881854 scopus 로고    scopus 로고
    • Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients
    • Association Francaise de Chirurgie
    • NORDLINGER B, GUIGUET M, VAILLANT JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996; 77: 1254-1262
    • (1996) Cancer , vol.77 , pp. 1254-1262
    • Nordlinger, B.1    Guiguet, M.2    Vaillant, J.C.3
  • 3
    • 0032791959 scopus 로고    scopus 로고
    • Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
    • GIACCHETTI S, ITZHAKI M, GRUIA G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 1999; 10: 663-669
    • (1999) Ann Oncol , vol.10 , pp. 663-669
    • Giacchetti, S.1    Itzhaki, M.2    Gruia, G.3
  • 4
    • 0028114794 scopus 로고
    • Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors
    • GAYOWSKI TJ, IWATSUKI S, MADARIAGA, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 1994; 116: 703-710
    • (1994) Surgery , vol.116 , pp. 703-710
    • Gayowski, T.J.1    Madariaga, I.S.2
  • 5
    • 0027207599 scopus 로고
    • Surgical treatment of liver metastases in patients with colorectal cancer
    • BALLANTYNE GH, QUIN J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer. 1993; 71 (12 Suppl): 4252-4266 (Pubitemid 23169104)
    • (1993) Cancer , vol.71 , Issue.12 SUPPL. , pp. 4252-4266
    • Ballantyne, G.H.1    Quin, J.2
  • 6
    • 0038600610 scopus 로고    scopus 로고
    • Chemotherapy and surgery: New perspectives on the treatment of unresectable liver metastases
    • ADAM R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol. 2003; 14 Suppl 2: ii13-6.
    • (2003) Ann Oncol , vol.14 , Issue.SUPPL. 2
    • Adam, R.1
  • 7
    • 0036787717 scopus 로고    scopus 로고
    • Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: A pilot study in patients with metastatic colorectal cancer
    • FALCONE A, MASI G, ALLEGRINI G, et al. Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer. J Clin Oncol. 2002; 20: 4006-4014
    • (2002) J Clin Oncol , vol.20 , pp. 4006-4014
    • Falcone, A.1    Masi, G.2    Allegrini, G.3
  • 9
    • 0032791959 scopus 로고    scopus 로고
    • Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
    • GIACCHETTI S, ITZHAKI M, GRUIA G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 1999; 10: 663-669
    • (1999) Ann Oncol , vol.10 , pp. 663-669
    • Giacchetti, S.1    Itzhaki, M.2    Gruia, G.3
  • 10
    • 0035018397 scopus 로고    scopus 로고
    • Five-year survival following hepatic resection after neoadjuvant therapy for non-resectable colorectal
    • ADAM R, AVISAR E, ARICHE A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for non-resectable colorectal. Ann Surg Oncol. 2001; 8: 347-353
    • (2001) Ann Surg Oncol , vol.8 , pp. 347-353
    • Adam, R.1    Avisar, E.2    Ariche, A.3
  • 11
    • 33644819672 scopus 로고    scopus 로고
    • Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group phase II study
    • ALBERTS SR, HORVATH WL, STERNFELD WC, et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol. 2005; 23: 9243-9249
    • (2005) J Clin Oncol , vol.23 , pp. 9243-9249
    • Alberts, S.R.1    Horvath, W.L.2    Sternfeld, W.C.3
  • 13
    • 33645269821 scopus 로고    scopus 로고
    • Triplet therapy with oxaliplatin, irinitecan, 5-fluorouracil and folinic acid within combined modality approach in patients with liver metastases from colorectal cancer
    • abstr 3593
    • de la CAMARA J, RODRIGUEZ J, ROTELLAR F, et al. Triplet therapy with oxaliplatin, irinitecan, 5-fluorouracil and folinic acid within combined modality approach in patients with liver metastases from colorectal cancer Proc Am Soc Clin Oncol, 2004, abstr 3593
    • (2004) Proc Am Soc Clin Oncol
    • De La Camara, J.1    Rodriguez, J.2    Rotellar, F.3
  • 14
    • 10744229419 scopus 로고    scopus 로고
    • European Association for Research in Oncology, Creteil, France. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial)
    • ZELEK L, BUGAT R, CHERQUI D, et al; European Association for Research in Oncology, Creteil, France. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). Ann Oncol. 2003; 14: 1537-1542
    • (2003) Ann Oncol , vol.14 , pp. 1537-1542
    • Zelek, L.1    Bugat, R.2    Cherqui, D.3
  • 15
    • 15744374738 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma
    • DOI 10.1200/JCO.2005.00.349
    • LEONARD GD, BRENNER B, KEMENY NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2005; 23: 2038-2048 (Pubitemid 46211384)
    • (2005) Journal of Clinical Oncology , vol.23 , Issue.9 , pp. 2038-2048
    • Leonard, G.D.1    Brenner, B.2    Kemeny, N.E.3
  • 16
    • 0033989203 scopus 로고    scopus 로고
    • Phase III multicenter randomized trial of oxaliplatin added to chrono-modulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
    • GIACCHETTI S, PERPOINT B, ZIDANI R, et al. Phase III multicenter randomized trial of oxaliplatin added to chrono-modulated fluorouracil- leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol. 2000; 18: 136-147
    • (2000) J Clin Oncol , vol.18 , pp. 136-147
    • Giacchetti, S.1    Perpoint, B.2    Zidani, R.3
  • 17
    • 84906140174 scopus 로고    scopus 로고
    • Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L13 OHP/LV5FU (Folfirinox): A prospective phase II trial
    • QUENET F, NORDLINGER B, RIVOIRE M, et al. Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L13 OHP/LV5FU (Folfirinox): A prospective phase II trial. Proc Am Soc Clin Oncol, 2002, 21: 143a
    • (2002) Proc Am Soc Clin Oncol , vol.21
    • Quenet, F.1    Nordlinger, B.2    Rivoire, M.3
  • 19
    • 33749016960 scopus 로고    scopus 로고
    • Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): Final analysis of the TREE-Study
    • Abs: 3510
    • Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): Final analysis of the TREE-Study. J Clin Oncol 24, 2006: Abs: 3510
    • (2006) J Clin Oncol , vol.24
  • 22
    • 0002294519 scopus 로고
    • Results of resection of metastatic tumors of the liver
    • Jan
    • WOODINGTON GF, WAUGH JM. Results of resection of metastatic tumors of the liver. Am J Surg. 1963 Jan; 105: 24-29
    • (1963) Am J Surg , vol.105 , pp. 24-29
    • Woodington, G.F.1    Waugh, J.M.2
  • 23
    • 0026761374 scopus 로고
    • Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma
    • FOWLER WC, EISENBERG BL, HOFFMAN JP. Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol. 1992; 51: 122-125
    • (1992) J Surg Oncol , vol.51 , pp. 122-125
    • Fowler, W.C.1    Eisenberg, B.L.2    Hoffman, J.P.3
  • 24
    • 23844448040 scopus 로고    scopus 로고
    • Neoadjuvant treatment of unresectable colorectal liver metastases: Correlation between tumour response and resection rates
    • DOI 10.1093/annonc/mdi246
    • FOLPRECHT G, GROTHEY A, ALBERTS S, et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol. 2005; 16: 1311-1319 (Pubitemid 41158476)
    • (2005) Annals of Oncology , vol.16 , Issue.8 , pp. 1311-1319
    • Folprecht, G.1    Grothey, A.2    Alberts, S.3    Raab, H.-R.4    Kohne, C.-H.5
  • 25
    • 6444243519 scopus 로고    scopus 로고
    • An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first line treatment of patients with metastatic colorectal cancer (CRC) expressing Epidermal Growth Factor Receptor (EGFR). Preliminary results
    • abstr 3512
    • TABERNO J, VAN CUSTEM E, SASTRE J, et al. An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first line treatment of patients with metastatic colorectal cancer (CRC) expressing Epidermal Growth Factor Receptor (EGFR). Preliminary results. Proc Am Soc Clin Oncol, 2004, 23: abstr 3512
    • (2004) Proc Am Soc Clin Oncol , vol.23
    • Taberno, J.1    Van Custem, E.2    Sastre, J.3
  • 26
    • 16244372110 scopus 로고    scopus 로고
    • Cetuximab + FOLFIRI as first line treatment for metastatic colorectal CA
    • abstr 3513
    • ROUGIER P, RAOUL JL, VAN LAETHEM JL, et al. Cetuximab + FOLFIRI as first line treatment for metastatic colorectal CA. Proc Am Soc Clin Oncol, 2004, 23: abstr 3513
    • (2004) Proc Am Soc Clin Oncol , vol.23
    • Rougier, P.1    Raoul, J.L.2    Van Laethem, J.L.3
  • 27
    • 6444230253 scopus 로고    scopus 로고
    • A phase II study of gefinitib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer
    • abstr 3514
    • FISHER GA, KUO T, CHO CD, et al. A phase II study of gefinitib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer. Proc Am Soc Clin Oncol, 2004, 23: abstr 3514
    • (2004) Proc Am Soc Clin Oncol , vol.23
    • Fisher, G.A.1    Kuo, T.2    Cho, C.D.3
  • 29
    • 0042130358 scopus 로고    scopus 로고
    • Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer: A single institution's experience
    • DOI 10.1016/S0936-6555(03)00019-0
    • SUMPTER K, HARPER-WYNNE C, CUNNINGHAM D, et al. Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer: a single institution's experience. Clin Oncol (R Coll Radiol). 2003; 15: 221-226 (Pubitemid 36950001)
    • (2003) Clinical Oncology , vol.15 , Issue.5 , pp. 221-226
    • Sumpter, K.1    Harper-Wynne, C.2    Cunningham, D.3    Gillbanks, A.4    Norman, A.R.5    Hill, M.6
  • 32
    • 0141852876 scopus 로고    scopus 로고
    • Influence of postoperative morbidity on longterm survival following liver resection for colorectal metastases
    • LAURENT C, SA CUNHA A, COUDERC P, et al. Influence of postoperative morbidity on longterm survival following liver resection for colorectal metastases. Br J Surg. 2003; 90: 1131-1136
    • (2003) Br J Surg , vol.90 , pp. 1131-1136
    • Laurent, C.1    Sa Cunha, A.2    Couderc, P.3
  • 34
    • 0030814028 scopus 로고    scopus 로고
    • Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie
    • JAECK D, BACHELLIER P, GUIGUET M, et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg. 1997; 84: 977-980
    • (1997) Br J Surg , vol.84 , pp. 977-980
    • Jaeck, D.1    Bachellier, P.2    Guiguet, M.3
  • 35
    • 0033504042 scopus 로고    scopus 로고
    • Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
    • FONG Y, FORTNER J, SUN RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230: 309-318
    • (1999) Ann Surg , vol.230 , pp. 309-318
    • Fong, Y.1    Fortner, J.2    Sun, R.L.3
  • 36
    • 0842310770 scopus 로고    scopus 로고
    • Liver resection for colorectal metastases: The third hepatectomy
    • ADAM R, PASCAL G, AZOULAY D, et al. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg. 2003; 238: 871-883
    • (2003) Ann Surg , vol.238 , pp. 871-883
    • Adam, R.1    Pascal, G.2    Azoulay, D.3
  • 37
    • 0028308472 scopus 로고
    • Factors influencing the natural history of colorectal liver metastases
    • STANGL R, ALTENDORF-HOFMANN A, CHARNLEY RM, SCHEELE J. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994; 343: 1405-1410
    • (1994) Lancet , vol.343 , pp. 1405-1410
    • Stangl, R.1    Altendorf-Hofmann, A.2    Charnley, R.M.3    Scheele, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.